On the basis of the observed WD‐induced reduction in intestinal IAP and subsequent increase in intestinal permeability leading to glucose intolerance, in this study we sought to examine the effects of intestine‐specific transgenic overexpression of IAP. The gene discussed is ALPI; the disease is Glucose intolerance.